FGFR1 and lung carcinoma: The FGF-based conjugates retained the receptor binding and cellular trafficking properties of unconjugated FGFs, and demonstrated a selective cytotoxic potential against FGFR1-overproducing lung cancer cell lines [196,197,198,199].